Jay H. Kleiman

7.6k total citations · 2 hit papers
20 papers, 5.5k citations indexed

About

Jay H. Kleiman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jay H. Kleiman has authored 20 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jay H. Kleiman's work include Hormonal Regulation and Hypertension (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Acute Myocardial Infarction Research (4 papers). Jay H. Kleiman is often cited by papers focused on Hormonal Regulation and Hypertension (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Acute Myocardial Infarction Research (4 papers). Jay H. Kleiman collaborates with scholars based in United States, France and Canada. Jay H. Kleiman's co-authors include Barbara Roniker, Richard M. Bittman, James D. Neaton, Faı̈ez Zannad, Marjorie Gatlin, Felipe A. Martínez, Bertram Pitt, Willem J. Remme, Scott Krause and F Zannad and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Jay H. Kleiman

20 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

2003 3.4k citations Bertram Pitt, Willem J. Remme et al. New England Journal of Medicine profile →
EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

2003 539 citations B. Pitt, F Zannad et al. profile →

Peers

Jay H. Kleiman

CCM

EDM

SURGE

PRM

Barbara Roniker United States

Marjorie Gatlin United States

F. H. M. Derkx Netherlands

Richard M. Bittman United States

Felipe A. Martínez United States

Enrico Agabiti Rosei Italy

Michel F. Rousseau Belgium

Agata Ptaszynska United States

Jean‐Pierre Cambou France

J Wertheimer United States

Barbara Roniker United States

Jay H. Kleiman

4.0k ×1.1

CCM

3.9k ×1.3

EDM

1.6k ×1.1

SURGE

1.2k ×1.2

PRM

958 ×1.3

Citations per year, relative to Jay H. Kleiman Jay H. Kleiman (= 1×) peers Barbara Roniker

Countries citing papers authored by Jay H. Kleiman

Since Specialization

Citations

This map shows the geographic impact of Jay H. Kleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Kleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Kleiman more than expected).

Fields of papers citing papers by Jay H. Kleiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay H. Kleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Kleiman. The network helps show where Jay H. Kleiman may publish in the future.

Co-authorship network of co-authors of Jay H. Kleiman

This figure shows the co-authorship network connecting the top 25 collaborators of Jay H. Kleiman. A scholar is included among the top collaborators of Jay H. Kleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay H. Kleiman. Jay H. Kleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burgess, Ellen, Suzanne Oparil, Jay H. Kleiman, et al.. (2003). Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Clinical Therapeutics. 25(9). 2388–2404. 57 indexed citations

Flack, John M., Suzanne Oparil, J. Howard Pratt, et al.. (2003). Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. Journal of the American College of Cardiology. 41(7). 1148–1155. 183 indexed citations

Pitt, Bertram, Willem J. Remme, Faı̈ez Zannad, et al.. (2003). Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction. New England Journal of Medicine. 348(14). 1309–1321. 3443 indexed citations breakdown →

Pitt, B., F Zannad, James D. Neaton, et al.. (2003). EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. 348. 1309–1321. 539 indexed citations breakdown →

Pitt, Bertram, Nathaniel Reichek, Roland Willenbrock, et al.. (2003). Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy. Circulation. 108(15). 1831–1838. 480 indexed citations

Pitt, Bertram, Faı̈ez Zannad, Richard M. Bittman, et al.. (2003). The EPHESUS trial: evaluation of eplerenone in the subgroup of patients with baseline left ventricular ejection fraction ≤30%. Journal of Cardiac Failure. 9(5). S57–S57. 3 indexed citations

Pitt, Bertram, Vivencio Barrios, Barbara Roniker, et al.. (2002). Efficacy and Safety of Eplerenone Compared to Enalapril in Left Ventricular Hypertrophy. Japanese Circulation Journal-english Edition. 66. 139. 1 indexed citations

Epstein, Murray, et al.. (2002). Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction. Journal of the American College of Cardiology. 39. 249–249. 32 indexed citations

Anders, Robert J., et al.. (2001). Xemilofiban/Orbofiban: Insight into Drug Development. Cardiovascular Drug Reviews. 19(2). 116–132. 18 indexed citations

10.

Pitt, Bertram, Gordon H. Williams, Willem J. Remme, et al.. (2001). The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction. Cardiovascular Drugs and Therapy. 15(1). 79–87. 259 indexed citations

11.

O’Neill, William W., Patrick W. Serruys, M.L. Knudtson, et al.. (2000). Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary Revascularization. New England Journal of Medicine. 342(18). 1316–1324. 156 indexed citations

12.

O’Neill, William W., Patrick W. Serruys, M.L. Knudtson, et al.. (1999). Design and Objectives of the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events (EXCITE) Study. Journal of Interventional Cardiology. 12(2). 109–116. 4 indexed citations

13.

Kleiman, Jay H., et al.. (1996). PTCA of complex atherosclerotic lesion at site of LAD myocardial bridging. Catheterization and Cardiovascular Diagnosis. 37(3). 272–276. 3 indexed citations

14.

Kleiman, Jay H., et al.. (1992). Aspiration of a mobile thromboembolus from saphenous vein graft. Catheterization and Cardiovascular Diagnosis. 27(1). 49–51. 2 indexed citations

15.

Martin, Randolph P., Harry Rakowski, Jay H. Kleiman, et al.. (1979). Reliability and reproducibility of two dimensional echocardiographic measurement of the stenotic mitral valve orifice area. The American Journal of Cardiology. 43(3). 560–568. 163 indexed citations

16.

Kleiman, Jay H., Edwin L. Alderman, Robert H. Goldman, et al.. (1979). Effects of digitalis on normal and abnormal left ventricular segmental dynamics. The American Journal of Cardiology. 43(5). 1001–1008. 16 indexed citations

17.

Kleiman, Jay H., Neil B. Ingels, George T. Daughters, et al.. (1978). Left ventricular dynamics during long-term digoxin treatment in patients with stable coronary artery disease. The American Journal of Cardiology. 41(5). 937–942. 24 indexed citations

18.

Kleiman, Jay H., et al.. (1978). Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. The American Journal of Cardiology. 42(2). 267–275. 42 indexed citations

19.

Kleiman, Jay H., Jorge Motta, Elizabeth London, J. P. Pennell, & Richard L. Popp. (1978). Pericardial effusions in patients with end-stage renal disease.. Heart. 40(2). 190–193. 10 indexed citations

20.

McLaughlin, Peter R., Jay H. Kleiman, R P Martin, et al.. (1978). The effect of exercise and atrial pacing on left ventricular volume and contractility in patients with innervated and denervated hearts.. Circulation. 58(3). 476–483. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact